Title:
自己免疫疾患の処置
Document Type and Number:
Japanese Patent JP7345182
Kind Code:
B2
Abstract:
The invention provides a novel approach to the treatment of autoimmune diseases, particularly multiple sclerosis, using a molecule capable of acting as substrate for the queuine-insertase enzyme complex.
Inventors:
Kelly, Vincent
Application Number:
JP2020006026A
Publication Date:
September 15, 2023
Filing Date:
January 17, 2020
Export Citation:
Assignee:
The Probost, Fellows, Foundation Scholars, And The Other Members of Board, of the College of the Horly and Andy Byeded Trinity of Queen Elizabeth Near Dublin
International Classes:
A61K45/00; A61P1/04; A61P3/10; A61P17/06; A61P19/02; A61P25/00; A61P29/00; A61P37/06; A61P43/00
Domestic Patent References:
| JP8311040A | ||||
| JP2501306A |
Other References:
VARGHESE SREEJA,THE QUEUINE-TRANSFER RNA PATHWAY AS A NOVEL DRUG MECHANISM TO TREAT MULTIPLE SCLEROSIS,A THESIS SUBMITTERD TO TRINITY COLLEGE DUBLIN,2012
Nucleic Acids Research,2017,Vol.45,No.4,p.2029-2039
Nucleic Acids Research,2017,Vol.45,No.4,p.2029-2039
Attorney, Agent or Firm:
Patent Attorney Corporation Tsukuni
Previous Patent: An antibody that specifically binds to the N-terminal region of lysyl-tRNA synthetase exposed on the...
Next Patent: gaming machine
Next Patent: gaming machine